Literature DB >> 7539804

The use of Tachocomb in thoracic surgery.

P Hollaus1, N Pridun.   

Abstract

Diffuse bleeding of the thoracic wall still remains a major problem in thoracic surgery. Especially after lysis of strong adhesions of the lung to the parietal pleura blood loss from multiple bleeding points can be quite extensive. The thoracic apex, poorly accessible to visual inspection and electrocoagulation for anatomic reasons, can be a major bleeding source too. The closure of multiple vascular leaks with fibrin sealant alone has not proven to be satisfactorily efficient, since fibrin often is washed away by the bleeding itself. With Tachocomb, a newly developed collagen patch, successful tamponade of large bleeding areas has now become possible. By local positioning of the patch the stopping of bleeding can be achieved easily and quickly. Another important use of Tachocomb in lung surgery is the closure of parenchymal leakage.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7539804

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  3 in total

1.  Safety and Hemostatic Effectiveness of the Fibrin Pad for Severe Soft-Tissue Bleeding During Abdominal, Retroperitoneal, Pelvic, and Thoracic (Non-cardiac) Surgery: A Randomized, Controlled, Superiority Trial.

Authors:  Jonathan Koea; Peter Baldwin; Jessica Shen; B Patel; Jonathan Batiller; Axel Arnaud; James Hart; Jeffrey Hammond; Craig Fischer; O James Garden
Journal:  World J Surg       Date:  2015-11       Impact factor: 3.352

2.  Pleural defect repair with an overlapping method using fibrin glue-coated collagen fleece.

Authors:  Noriyuki Matsutani; Yuichi Ozeki
Journal:  Surg Today       Date:  2011-08-26       Impact factor: 2.549

3.  Safety and hemostatic efficacy of fibrin pad in partial nephrectomy: results of an open-label phase I and a randomized, standard-of-care-controlled phase I/II study.

Authors:  Ofer Nativ; Bababhai Patel; Jessica Shen; Jonathan Batiller; Sara Horn; James C Hart
Journal:  BMC Nephrol       Date:  2012-11-08       Impact factor: 2.388

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.